Optoretinography is coming of age.
Optoretinography is coming of age.
复制标题
视网膜检光术正在成熟。
DOI:
10.1073/pnas.2119737118
复制
发表时间:
2021
影响因子:
11.1
通讯作者:
Roorda,Austin
中科院分区:
文献类型:
--
作者:
Roorda,Austin
The arsenal of tools available to today’s neuroscientists to study the function and structure of neurons in the brain and retina is impressive. Fluorescent probes that indicate functional activity are becoming faster and more sensitive (1), as are the imaging systems that are being developed to observe them (2). Electrode arrays are becoming increasingly parallelized in three dimensions (3), and combined optoelectrical recording is also possible (4). But as exciting as these technologies are, their translation for human use remains problematic because of ethical and regulatory barriers arising from their invasiveness and potential toxicity. The increased demand for cellular-level recording with comparable sensitivity and resolution noninvasively in live humans has driven invention and innovation for the retina in an emerging area called optoretinography, or ORG. Originally coined by Mulligan et al.(5), ORG generally refers to the recording of optical signals caused by retinal neuronal function. ORG measurements with various names and realizations have been conducted for decades (6–11). A primary goal of ORG research has been to improve the ability to detect and measure loss of function due to disease, and thus Lassoued et al.’s (12) demonstration in PNAS that eye disease causes a change in the ORG represents the method’s coming of age. It took a combination of several major developments to reach this point. One of the major barriers was the eye’s natural optics, which have evolved nicely for vision, but are not of sufficient quality to enable microscopic images of the retina. These barriers were overcome in 1997 when a team led by David Williams at the University of Rochester—which also included DT Miller, the senior author of the study by Lassoued et al.(12)—used adaptive optics (AO) to measure and correct for aberrations in the eye and recorded retinal images with resolved cone photoreceptor cells in a live human (13). Since that time, AO technology has continued to mature, to the point where near-diffraction-limited optical resolution is now routine (14). Another major development was optical coherence tomography (OCT), which leverages the interference properties of light to make depth-resolved measurements (15). This technology was perfectly suited for imaging the weakly scattering, mostly transparent, tissue of the retina and allowed cross-sectional and three-dimensional imaging of the human retina (Fig. 1). Its use in clinical eye care is now commonplace (16). The integration of AO into OCT made it possible to resolve retinal cells in three dimensions. Until recently, the axial depth resolution of OCT was primarily obtained through the amplitude of the interference signal only, which already offered axial resolutions that were over an order of magnitude better than confocal optics could ever provide in a human eye (17). More recently, phase-resolved OCT has pushed axial resolution a giant leap further, offering sensitivities to physical changes in neurons on a nanometer scale. The basic premise of the ORG measurement as reported by Lassoued et al.(12) is this: When a neuron like a photoreceptor is excited, physical changes in the cell take place that lengthen or shorten the optical path length between its scattering surfaces. In phaseresolved OCT, these path length changes are big enough to manifest as measurable changes in the phase of the light waves returned from the eye. The phase is very sensitive to movement in the tissue; for relatively bright structures such as the photoreceptors, displacements smaller than 10 nm are detectable, much smaller than the axial resolution of the system or the wavelength of the imaging light. What are …